Based on the role of S100A8-elicited NLRP3 pyroptosis in liver fibrosis, we chose a well-defined cohort of liver fibrosis patients to assess the clinical importance of circulating S100A8, GSDMD, IL-1β, and IL-18 for predicting the occurrence and progression of disease. Here, NLRP3 is linked to Hepatic fibrosis.